←
Precigen257 posts
Precigen avatar

Precigen

@Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases

◷ Joined January 2018▧ 217 Photos and videos
Precigen avatar
Precigen@Precigen·25 Aug 2025

#Precigen to participate in upcoming virtual fireside chats hosted by Cantor and H.C. Wainwright to discuss the recent approval of the first and only FDA-approved therapy for the treatment of adults with RRP. View event details: bit.ly/41VSmMT

Post attachment
NIH avatar
⟳ Precigen retweeted
NIH@NIH·20 Aug 2025

NIH is thrilled to announce that the @US_FDA has granted full market approval for Papzimeos, a groundbreaking immunotherapy for adult patients with recurrent respiratory papillomatosis (RRP), a rare condition in which noncancerous growths develop in the air passages from the nose and mouth into the lungs.🫁 This is the first-ever non-surgical treatment for this rare and debilitating disease. The achievement was made possible through the dedicated research of NIH investigators from @theNCI! 🔗 Read more about the approval: fda.gov/news-events/press-an…

Post attachment
U.S. FDA avatar
⟳ Precigen retweeted
U.S. FDA@FDA·14 Aug 2025

Today, we approved a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent respiratory papillomatosis. fda.gov/news-events/press-an…

Post attachment
Precigen avatar
Precigen@Precigen·4 Jun 2024

Only 1 week to go until RRP Awareness Day, a multi-stakeholder event to raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials. View details at rrpawareness.org and join us!

Post attachment